Cephea Valve Technologies, Inc.
USPTO PatentsView assignee record - 62 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Cephea ranks #5,504 of 49,997 tracked US assignees by granted-patent volume, with 62 patents across 5 technology areas.
- #5,504
- of 49,997 US assignees by volume
- Top 44%
- by Innovation Score (37.4/100)
- 17.0
- avg claims per patent
- +309%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5504 · US Corporation #5,504 · 62 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 62 grants
- UPPER-Q #5,504/49,997
- PHOTO-FINISH Brio Water Technology
- CPC-NARROW A61F · 5 areas
- INNOV-THIN 37.4/100
- CLAIMS-RICH 17.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +309% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Brio Water Technology, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Cephea’s 37.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Cephea
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Arria Data2text · near
Arria Data2text · near
37 score
- Cambridge Internatio… · near
Cambridge Internatio… · near
37 score
- Cephea Valve · this assignee
Cephea Valve · this assignee
37 score
- Wireless Future · near
Wireless Future · near
37 score
- Zhuhai Kelitong · near
Zhuhai Kelitong · near
37 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Cephea's Innovation Score is 37.4/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Cephea?
Each dot is one of Cephea’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cephea’s own 17.0 claims/patent is at or below the 17.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Cephea's grants concentrate
Cephea Valve Technologies, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 95.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (13 grants) versus a trough of 2 in 2016. By volume, Cephea sits between Brio Water Technology, Inc. and Evident Corporation.
Cephea's three-year grant acceleration
From 2019–2021 to 2022–2024, Cephea Valve Technologies, Inc. moved from 28 to 21 grants (0.75x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Cephea's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Brio Water Techno…
Brio Water Technology, Inc.
62 patents
- C/HCA
C/HCA, Inc.
62 patents
- Chemtreat
Chemtreat, Inc.
62 patents
- Caavo
Caavo Inc
62 patents
- Cleerly
Cleerly, Inc.
62 patents
- Dspace
Dspace GMBH
62 patents
- Egnyte
Egnyte, Inc.
62 patents
- Evident
Evident Corporation
62 patents
- Cephea Valve ◀
Cephea Valve Technologies, Inc.
62 patents
What this shows Cephea holds 62 patents at rank #5,506, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Cephea
By rank, the assignees closest to #5,506 in granted patent volume.
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Cephea's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Cephea, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Cephea ranks #97 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (37 here).
Similar claim depth
Nearest assignees by average claims per patent (17.0 here).
Cephea's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 44% higher than 56% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 3.2% |
| 2017 | 2 | 3.2% |
| 2018 | 3 | 4.8% |
| 2019 | 4 | 6.5% |
| 2020 | 13 | 21.0% |
| 2021 | 11 | 17.7% |
| 2022 | 6 | 9.7% |
| 2023 | 11 | 17.7% |
| 2024 | 4 | 6.5% |
| 2025partial year | 6 | 9.7% |
Which technologies does Cephea Valve Technologies, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Cephea Valve Technologies, Inc.'s patent record in context - here's where to go next.
- Cephea Valve Technologies, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 95.2% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #5,504 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Cephea Valve Technologies, Inc. against Brio Water Technology, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 37.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.